{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:55Z","timestamp":1759403455072,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2020.12.071","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T03:01:27Z","timestamp":1611025287000},"page":"1165-1172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic"],"prefix":"10.1016","volume":"39","author":[{"given":"Aline Alencar M.F.","family":"Nic\u00e1cio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oct\u00e1vio A.B.","family":"Peracchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-1053","authenticated-orcid":false,"given":"Melissa M.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Sylvia","family":"Vitalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"de Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Terreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.12.071_b0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.071_b0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0482-50042010000400002","article-title":"Pr\u00e1tica de vacina\u00e7\u00e3o em crian\u00e7as com doen\u00e7as reum\u00e1ticas (Vaccination practice in children with rheumatic diseases)","volume":"50","author":"Silva","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0015","doi-asserted-by":"crossref","unstructured":"Petty RE, Cassidy JT. Chronic arthritis in childhood. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (Ed). Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2011. P.211\u2013235","DOI":"10.1016\/B978-1-4160-6581-4.10013-5"},{"key":"10.1016\/j.vaccine.2020.12.071_b0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-015-0519-y","article-title":"Vaccinations in Paediatric Rheumatology: an update on current developments","volume":"17","author":"Groot","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.vaccine.2020.12.071_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","article-title":"Juvenile idiopathic arthritis: diagnosis and treatment","volume":"3","author":"Giancane","year":"2016","journal-title":"Rheumatol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.071_b0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1590\/S0482-50042009000500007","article-title":"Consenso de imuniza\u00e7\u00e3o para crian\u00e7as e adolescentes com doen\u00e7as reum\u00e1ticas","volume":"49","author":"Silva","year":"2009","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0035","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.vaccine.2012.02.013","article-title":"Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"30","author":"Tomovici","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.071_b0040","unstructured":"Caldera F, Saha S, Wald A, Garmoe CA, McCrone S, Megna B et al. Lower sustained diphtheria and pertussis antibody concentrations in inflammatory bowel disease patients. Digestive Diseases and Sciences. Available at: http:\/\/doi.org\/10.1007\/s10620-018-5043-2; 2018 Accessed 28.01.19."},{"key":"10.1016\/j.vaccine.2020.12.071_b0045","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.12.071_b0050","first-page":"2290","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera","volume":"105","author":"Kristiansen","year":"1997","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.vaccine.2020.12.071_b0060","unstructured":"Borrow R, Balmer P, Roper MH. The immunological basis for immunization series. Module 3: Tetanus. Geneva: World Health Organization. 2006; 1-52."},{"key":"10.1016\/j.vaccine.2020.12.071_b0065","doi-asserted-by":"crossref","unstructured":"Scheifele DW, Ochnio JJ. The immunological basis for immunization series. Module 2: Diphtheria. Geneva: World Health Organization. 2009: 1-28.","DOI":"10.1097\/INF.0b013e3181a9cc2a"},{"key":"10.1016\/j.vaccine.2020.12.071_b0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"Wirsing von K\u00f6nig CH, EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.12.071_b0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2015.11.049","article-title":"Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults","volume":"34","author":"Gr\u00f6ndahl-Yli-Hannuksela","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.071_b0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.it.2014.06.002","article-title":"Phenotype and functions of memory Tfh cells in human blood","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0090","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2012.06.073","volume":"30","author":"Thierry-Carstensen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.071_b0095","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1016\/j.vaccine.2011.07.068","article-title":"Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4\u20135 years after a previous dose","volume":"29","author":"Halperin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.071_b0100","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1001\/jama.293.24.3003","article-title":"Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults","volume":"293","author":"Pichichero","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.12.071_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/596201","article-title":"Adverse events after administration of tetanus-diphtheria-acellular pertussis vaccine to health care workers","volume":"30","author":"Sandora","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2020.12.071_b0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.vaccine.2008.11.028","article-title":"Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19\u201364 years of age","volume":"27","author":"Blatter","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.071_b0115","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/ar2824","article-title":"Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis","volume":"11","author":"Corcione","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.071_b0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/BOR.0b013e3283369cb8","article-title":"B cells in the pathogenesis and treatment of rheumatoid arthritis","volume":"22","author":"Marston","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.071_b0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/art.40410","article-title":"Switched memory B cells are increased in oligoarticular and polyarticular juvenile idiopathic arthritis and their change over time is related to response to tumor necrosis factor inhibitors","volume":"70","author":"Marasco","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.vaccine.2020.12.071_b0130","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.38736","article-title":"Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis","volume":"66","author":"Glaesener","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2020.12.071_b0135","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4049\/jimmunol.1500591","article-title":"CD56 bright CD162 NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2020.12.071_b0140","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/rheumatology\/kev101","article-title":"Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis","volume":"54","author":"Bulatovi\u0107 \u0106alasan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2020.12.071_b0145","unstructured":"Von K\u00f6nig CHW, Guiso N. The immunological basis for immunization series. Module 4: Pertussis Update 2017. Geneva: World Health Organization. 2017: 1-69."},{"key":"10.1016\/j.vaccine.2020.12.071_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003264","article-title":"Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine","volume":"9","author":"Ross","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.12.071_b0155","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1016\/j.vaccine.2018.07.043","article-title":"Immune response to a Tdap booster in vertically HIV-infected adolescents","volume":"36","author":"Spina","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.071_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12969-017-0190-0","article-title":"Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay","volume":"15","author":"Camacho-Lovillo","year":"2017","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20316686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:12Z","timestamp":1759402332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20316686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X20316686"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}